Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
AIM ImmunoTech Inc. is an immuno-pharma company based in Ocala, Florida, focused on developing therapeutics for cancer, viral diseases, and immune disorders. Its flagship products, Ampligen and Alferon N Injection, target unmet medical needs. AIM is exploring Ampligen's potential in pancreatic cancer and as an antiviral treatment, including for COVID-19. The company is actively conducting clinical trials and seeking FDA approval to expand its market presence.
This description was generated via AI from an annual report. Updated about 1 year ago.